Institutional Ownership
Halozyme Therapeutics Inc
CUSIP 40637HAD1NOTE 0.250% 3/0HALOQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
14
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Tpg Gp A, LLC | 10.00M | $10.37M |
| 2 | Balyasny Asset Management L.P. | 6.20M | $6.46M |
| 3 | Focus Partners Wealth | 3.75M | $3.88M |
| 4 | Rational Advisors, Inc. | 2.97M | $3.08M |
| 5 | Bnp Paribas Asset Management Holding S.A. | 2.65M | $2.74M |
| 6 | Ssi Investment Management LLC | 1.30M | $1.35M |
| 7 | Oppenheimer Asset Management Inc. | 170.0K | $176.3K |
| 8 | &Partners | 130.0K | $134.8K |
| 9 | Mariner, LLC | 59.0K | $61.0K |
| 10 | Stephens Inc /Ar/ | 53.0K | $55.0K |